Article Details
Retrieved on: 2021-09-02 12:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
02, 2021 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biotechnology company pioneering a new class of immuno-oncology agents ...
Article found on: www.bakersfield.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here